Seifert Martina, Bayrak Alexandra, Stolk Meaghan, Souidi Naima, Schneider Maria, Stock Ulrich A, Brockbank Kelvin G M
Institute of Medical Immunology, Charité Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany; Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.
Institute of Medical Immunology, Charité Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany; Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.
J Surg Res. 2015 Feb;193(2):933-41. doi: 10.1016/j.jss.2014.10.016. Epub 2014 Oct 17.
Undesirable processes of inflammation, calcification, or immune-mediated reactions are limiting factors in long-term survival of heart valves in patients. In this study, we target the modulatory effects of ice-free cryopreservation (IFC) of xenogeneic heart valve leaflet matrices, without decellularization, on the adaptive human immune responses in vitro.
We tested porcine leaflet matrices from fresh untreated, conventionally cryopreserved (CFC), and IFC pulmonary valves by culturing them with human blood mononuclear cells for 5 d in vitro. No other tissue treatment protocols to modify possible immune responses were used. Matrices alone or in addition with a low-dose second stimulus were analyzed for induction of proliferation and cytokine release by flow cytometry-based techniques. Evaluation of the α-Gal epitope expression was performed by immunohistochemistry with fluorochrome-labeled B4 isolectin.
None of the tested leaflet treatment groups directly triggered the proliferation of immune cells. But when tested in combination with a second trigger by anti-CD3, IFC valves showed significantly reduced proliferation of T cells, especially effector memory T cells, in comparison with fresh or CFC tissue. Moreover, the cytokine levels for interferon-γ (IFNγ), tumor necrosis factor α, and interleukin-10 were reduced for the IFC-treated group being significantly different compared with the CFC group. However, no difference between treatment groups in the expression of the α-Gal antigen was observed.
IFC of xenogeneic tissue might be an appropriate treatment method or processing step to prevent responses of the adaptive immune system.
炎症、钙化或免疫介导反应等不良过程是患者心脏瓣膜长期存活的限制因素。在本研究中,我们针对异种心脏瓣膜小叶基质的无冰冷冻保存(IFC)在体外对适应性人类免疫反应的调节作用,该过程未进行脱细胞处理。
我们通过将新鲜未处理、传统冷冻保存(CFC)和IFC肺动脉瓣的猪小叶基质与人类血液单核细胞在体外培养5天来进行测试。未使用其他改变可能免疫反应的组织处理方案。通过基于流式细胞术的技术分析单独的基质或添加低剂量二次刺激后的基质,以诱导增殖和细胞因子释放。通过用荧光染料标记的B4异凝集素进行免疫组织化学来评估α-Gal表位表达。
所有测试的小叶处理组均未直接触发免疫细胞的增殖。但当与抗CD3二次触发联合测试时,与新鲜或CFC组织相比,IFC瓣膜显示T细胞增殖显著降低,尤其是效应记忆T细胞。此外,IFC处理组的干扰素-γ(IFNγ)、肿瘤坏死因子α和白细胞介素-10细胞因子水平降低,与CFC组相比有显著差异。然而,各处理组之间在α-Gal抗原表达上未观察到差异。
异种组织的IFC可能是预防适应性免疫系统反应的合适治疗方法或处理步骤。